EYENOVIA INC. - COMMO
0,0889
25-ноября-24 16:45:01
15 мин. задержка
Акции
-0,0187
-17,38%
Сегодняшний диапазон
0,0790 - 0,0984
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Eyenovia Announces $12 Million Registered Direct Offering
24 авг 2023 18:47:29 Источник Nasdaq GlobeNewswire
-
16 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update
10 авг 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference
09 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Eyenovia to Report Second Quarter 2023 Results on Thursday, August 10
07 авг 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Eyenovia Announces First Commercial Sale of Mydcombi™
03 авг 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Eyenovia Announces Addition to Russell 2000® and Russell 3000® Indexes
26 июн 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Eyenovia Announces Presentation at the OCTANE Ophthalmology Tech Forum 2023
01 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Eyenovia Reports First Quarter 2023 Financial Results and Provides Business Update
11 май 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
08 май 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Eyenovia to Report First Quarter 2023 Results on Thursday, May 11
04 май 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Eyenovia Announces Poster Presentation at ARVO 2023
24 апр 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Eyenovia Reports Fourth Quarter 2022 Financial Results and Provides Business Update
30 мар 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Eyenovia to Report Fourth Quarter and Full-Year 2022 Results on Thursday, March 30
23 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
28 фев 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Eyenovia Announces Development Collaboration Agreement with Formosa Pharmaceuticals
15 фев 2023 09:51:05 Источник Nasdaq GlobeNewswire
-
12 янв 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Eyenovia Announces Participation at the 2023 International Consumer Electronics Show
20 дек 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi™ for In-Office Pupil Dilation
13 дек 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Eyenovia Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice President
08 дек 2022 08:00:01 Источник Nasdaq GlobeNewswire